Engaging Families to Improve the Care of Patients With Hypospadias

Reconstructive surgery is advocated for most children with hypospadias, a condition in which the pee hold is not in the correct place on the penis, to prevent potentially serious cosmetic and functional problems. Parents faced with a decision about hypospadias repair encounter an irreversible choice with potentially lifelong consequences. Recent studies have identified decisional conflict (DC) and decisional regret (DR) as a significant problem for parents. Several recent guidelines on complex urologic topics suggest that shared decision-making (SDM) is the optimal approach.

A pilot test of a decision aid website by parents potentially facing this decision will be conducted to measure pre- and post-outcomes, in order to develop a fuller understanding of how urologists can effectively provide parents with optimal decision support. Parents will answer questions via phone up to four time points, twice before (T1 and T2) and twice after seeing a urologist for a hypospadias referral (T3 and T4). If the urologist diagnoses hypospadias but recommends no surgery, the final data collection point will be three months after the urology visit. If the urologist recommends repair surgery, the final data collection point will be six months after surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Indiana University
    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • UNC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 5 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • parents 18 years of age and older of sons with hypospadias, or a tentative hypospadias diagnosis, and/or referral to a urologist for hypospadias
  • patient newborn up to age 5 years
  • parent able to consent and do interview in English
  • parent access to a reliable internet and smart phone, tablet, or computer to view the website
  • child/patient scheduled to see a urologist, but must not have yet seen the urologist at the time of enrollment
  • parent aware that there is an issue with child's pee hole
  • parent planning to attend urology appointment

Exclusion Criteria:

  • As target enrollment groups are filled, parents may be excluded in order to achieve a balanced sample, e.g. exclusion of mothers/female caregivers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Parent Utilization of Decision Aid Website
All enrolled parents will view the decision aid website for as long and as frequently as they wish before the initial visit to the urologist.
The (private) decision aid website contains information in text, graphic, and video form about hypospadias and considerations for choosing surgery and no surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent of Eligible Parents Screened (Feasibility)
Time Frame: Baseline (T1)
Recruitment is defined as the number of potential participants who are eligible divided by the total number screened multiplied by 100.
Baseline (T1)
Percent of Eligible Parents Enrolled (Feasibility)
Time Frame: Baseline (T1)
The number of parents enrolled divided by the total number of parents who were eligible multiplied by 100.
Baseline (T1)
Decision Aid Acceptability by Categories of Information, Length, Clarity, and Balance (Acceptability)
Time Frame: Pre-consultation, 1 week after baseline (T2)
Acceptability of a decision aid refers to ratings regarding the comprehensibility of components of a decision aid, its length, clarity, amount of information, and balance in presentation of information about options. The tool has 4 questions with answers on a Likert scale ranging from 1-5 (length, amount of information, and balance) and 1-4 (clarity). A response of 3 is ideal for information, length, and balance and a response of 1 is ideal for clarity.
Pre-consultation, 1 week after baseline (T2)
Percentage of Parents Retained in the Study (Feasibility)
Time Frame: T1 to T4, a total of approximately 6 months
Number of parents who completed the study divided by the number of eligible parents enrolled who completed the study multiplied by 100.
T1 to T4, a total of approximately 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Decisional Conflict Scale (DCS) Score at T1 and T2
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
The Decisional Conflict Scale (DCS) measures personal perceptions of uncertainty in choosing options, modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making, and effective decision making (in full version) such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice. This study utilizes the full version, a Likert-type scale consisting of 16 questions and answer options of strongly agree to strongly disagree. Total scores range from 0-100, a higher score means more decisional conflict.
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
Mean Decisional Conflict Scale (DCS) Score at T2 and T3
Time Frame: Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
The Decisional Conflict Scale (DCS) measures personal perceptions of uncertainty in choosing options, modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making, and effective decision making (in full version) such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice. This study utilizes the full version, a Likert-type scale consisting of 16 questions and answer options of strongly agree to strongly disagree. Total scores range from 0-100, a higher score means more decisional conflict. Time frame revised to address original entry error.
Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
Mean Decision-Specific Knowledge Scores
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
Decision-Specific Knowledge is a six-question tool with multiple choice question and answer options created by the investigator to measure pre/post knowledge of hypospadias and repair surgery. Total scores range from 0-100% with a higher score indicating more correct answers.
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
Mean Decisional Regret Scale Score
Time Frame: 3-month post-consultation (T4)
The Decision Regret Scale measures distress or remorse after a decision. Brehaut's (2003) 5-item scale has scores ranging from 0-100, where 100 indicates maximal regret, and 0 indicates no regret.
3-month post-consultation (T4)
Hypospadias Treatment Preference by Category at T1 and T2
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
This is a single question created by the investigator asking "Do you intend for your son to have hypospadias surgery?" with yes/no/unsure answer options to measure a change in response, or not, after viewing the decision aid website.
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
Hypospadias Treatment Preference by Category at T2 and T3
Time Frame: Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
This is a single question created by the investigator asking "Do you intend for your son to have hypospadias surgery?" with yes/no/unsure answer options to measure a change in response, or not, after viewing the decision aid website.
Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
Awareness of Decision by Category at T1 and T2
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
This is a single question created by the investigator asking "Is there a decision to make about whether your son should have surgery for his hypospadias?" with yes/no/unsure answer options to measure a change in awareness of decision, or not, after viewing the decision aid website.
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
Awareness of Decision by Category at T2 and T3
Time Frame: Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
This is a single question created by the investigator asking "Is there a decision to make about whether your son should have surgery for his hypospadias?" with yes/no/unsure answer options to measure a change in awareness of decision, or not, after viewing the decision aid website.
Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
Mean Shared Decision Making Questionnaire Score
Time Frame: Initial post-consultation, within 48 hours of urology visit (T3)
The Shared Decision Making Questionnaire measures the decisional process in medical encounters from both the patient and the physician perspectives. The questionnaire contains 9 questions with answers on a 6-point Likert scale. Scores range from 0-100 with higher scores indicating a higher perceived level of shared decision making.
Initial post-consultation, within 48 hours of urology visit (T3)
Mean Preparation for Decision Making Score
Time Frame: Pre-consultation, 1 week after baseline (T2)
The Preparation for Decision Making scale (Prep-DM) scale assesses a patient's perception of how useful a decision aid or other decision support intervention is in preparing the respondent to communicate with their practitioner at a consultation focused on making a health decision. The scale contains 10 questions with answers on a Likert Scale Scores range from 0-100 with higher scores indicating a higher perceived level of preparation for decision making.
Pre-consultation, 1 week after baseline (T2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katherine Hubert Chan, MD, MPH, University of North Carolina, Chapel Hill

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 9, 2021

Primary Completion (Actual)

October 6, 2022

Study Completion (Actual)

October 6, 2022

Study Registration Dates

First Submitted

August 31, 2021

First Submitted That Met QC Criteria

September 15, 2021

First Posted (Actual)

September 24, 2021

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 2, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypospadias

Clinical Trials on Decision Aid Website

Subscribe